Answers are grounded in this paper and cite their sources.
Initial PIM use was high and increased towards death. Discontinuation was observed in only one in five PIM users. More guidance for discontinuation of PIMs is needed: practical, evidence-based deprescribing guidelines and implementation plans, training for prescribers and a better consensus on what inappropriate medication is.
No takes yet. Share an insight, caveat, or question.
Paque et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: